Bicocca Open Archive

Logo unimib boa
CAVALETTI, GUIDO ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 49.306
EU - Europa 25.107
AS - Asia 14.530
SA - Sud America 764
OC - Oceania 115
AF - Africa 109
Continente sconosciuto - Info sul continente non disponibili 60
Totale 89.991
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 48.380
SG - Singapore 5.687
IT - Italia 4.747
CN - Cina 4.284
DE - Germania 3.941
RU - Federazione Russa 3.665
SE - Svezia 3.264
IE - Irlanda 3.173
UA - Ucraina 2.453
HK - Hong Kong 2.224
GB - Regno Unito 1.125
CA - Canada 869
FI - Finlandia 660
BR - Brasile 652
AT - Austria 557
VN - Vietnam 494
FR - Francia 420
ID - Indonesia 387
IN - India 364
DK - Danimarca 270
NL - Olanda 261
TR - Turchia 224
JP - Giappone 214
KR - Corea 194
BE - Belgio 139
AU - Australia 92
IR - Iran 83
PL - Polonia 70
ES - Italia 65
TW - Taiwan 55
EU - Europa 53
PK - Pakistan 40
CZ - Repubblica Ceca 39
MY - Malesia 38
CH - Svizzera 35
PT - Portogallo 34
MX - Messico 32
RO - Romania 31
IL - Israele 30
ZA - Sudafrica 27
EG - Egitto 26
AR - Argentina 25
UZ - Uzbekistan 25
EC - Ecuador 24
GR - Grecia 24
IQ - Iraq 24
NZ - Nuova Zelanda 23
HR - Croazia 20
PH - Filippine 20
BD - Bangladesh 19
PE - Perù 18
NO - Norvegia 17
MA - Marocco 15
SA - Arabia Saudita 15
AE - Emirati Arabi Uniti 14
BG - Bulgaria 14
CL - Cile 14
KG - Kirghizistan 14
RS - Serbia 13
TH - Thailandia 13
AZ - Azerbaigian 10
SC - Seychelles 10
AL - Albania 9
CO - Colombia 9
JO - Giordania 9
VE - Venezuela 9
HU - Ungheria 8
LV - Lettonia 8
MD - Moldavia 8
KZ - Kazakistan 7
LT - Lituania 7
LU - Lussemburgo 7
PY - Paraguay 7
TN - Tunisia 7
GT - Guatemala 6
SK - Slovacchia (Repubblica Slovacca) 6
LB - Libano 5
PA - Panama 5
SI - Slovenia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BH - Bahrain 4
BO - Bolivia 4
BY - Bielorussia 4
CR - Costa Rica 4
DZ - Algeria 4
JM - Giamaica 4
MT - Malta 4
MU - Mauritius 4
NG - Nigeria 4
OM - Oman 4
A1 - Anonimo 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GE - Georgia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
AF - Afghanistan, Repubblica islamica di 2
AO - Angola 2
BN - Brunei Darussalam 2
Totale 89.963
Salva come PNG Salva come JPEG
Città #
Ann Arbor 9.449
Woodbridge 4.641
Singapore 3.658
Fairfield 3.560
Houston 3.434
Dublin 3.078
Chandler 2.845
Jacksonville 2.527
Frankfurt am Main 2.307
Wilmington 2.277
Ashburn 2.244
Hong Kong 2.167
Dearborn 1.763
Milan 1.505
Seattle 1.385
Princeton 1.244
New York 1.236
Santa Clara 1.187
Cambridge 1.184
Nanjing 720
Boardman 578
Shanghai 504
Vienna 470
Lawrence 459
Altamura 450
Hangzhou 450
Beijing 429
Lachine 413
Jakarta 356
Guangzhou 260
Dong Ket 256
Council Bluffs 237
Nanchang 219
Helsinki 205
Andover 204
San Diego 202
Toronto 201
Moscow 199
Shenyang 195
Rome 172
Hebei 154
Falls Church 134
Los Angeles 133
Chicago 130
Nuremberg 126
Tianjin 126
Ottawa 119
Changsha 116
Fremont 116
Jiaxing 116
Brussels 113
Grafing 112
Kazan 112
Jinan 110
Mountain View 100
London 92
Norwalk 88
Huizen 85
Pune 85
Detroit 80
Kunming 75
Carate Brianza 74
Ningbo 71
Zhengzhou 67
Nürnberg 58
Melzo 57
Hefei 55
Dallas 54
Florence 54
Tokyo 54
São Paulo 51
Edmonton 50
Washington 48
San Mateo 47
Munich 44
Redmond 43
Leawood 38
Daejeon 37
Turin 37
Lissone 34
Sydney 34
Phoenix 33
Bergamo 32
Paris 32
Taizhou 32
Philadelphia 31
Sacramento 31
Bologna 30
Kiev 29
Naples 29
Auburn Hills 28
Rio de Janeiro 28
Bari 27
Lappeenranta 27
Saint Petersburg 27
University Park 27
Brno 26
Catania 26
Romola 26
Kocaeli 24
Totale 62.744
Salva come PNG Salva come JPEG
Nome #
La citofluorimetria a flusso nella caratterizzazione immunofenotipica dei linfociti in corso di Encefalite Autoimmune Sperimentale. 530
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice 423
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 414
Nelarabine-Induced Neurotoxicity: Reversible Damage not only on Peripheral Nerves 373
Comparing the different response of PNS and CNS injured neurons to mesenchymal stem cell treatment 366
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models 348
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 335
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 328
Malattie del Sistema Nervoso 322
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings 321
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes 318
Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells 317
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 312
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 310
Age-related changes in the function and structure of the peripheral sensory pathway in mice 308
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 305
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 303
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 299
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 296
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis 292
ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION 286
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 284
ETNK1 mutations promote ROS production and DNA damage through increased mitochondrial activity 280
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 278
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 278
The Italian multiple sclerosis register 275
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa 264
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 262
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 261
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 259
Enhanced brain targeting of engineered solid lipid nanoparticles 258
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents 258
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 252
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 249
Glutamatergic Homeostasis Impairment in Multiple Sclerosis Patients 244
Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling 244
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 243
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 242
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 238
Malattie del Sistema Nervoso 237
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 237
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 236
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 230
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 229
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 228
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 228
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings 226
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 226
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease 225
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 224
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 224
Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y 223
Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: A genome-wide study replication and meta-analysis 222
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 222
Are sigma receptor modulators a weapon against multiple sclerosis disease? 221
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 220
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 216
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 216
Role of MAPKs in platinum-induced neuronal apoptosis 215
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 213
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 213
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 210
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 208
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 206
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 206
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 206
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents 206
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 205
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 205
An unusual transthyretin gene missense mutation (TTR Phe33Val) linked to familial amyloidotic polyneuropathy 202
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline 202
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 200
Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis 197
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 197
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 195
Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells 194
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 194
Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation 193
Pain in chemotherapy-induced peripheral neurotoxicity 193
Effect of recombinant human nerve growth factor on cisplatin neurotoxicity in rats 192
Histological features of nerve fibers and endoneural vessels in a case of Wegener's granulomatosis. 192
Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer 192
Neuropathic pain and chemotherapy-induced peripheral neurotoxicity: the issue 192
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 192
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 192
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 191
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 191
NCI Clinical Trials Planning Meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy 191
Hemorrhagic infarction: risk factors, clinical and tomographic features, and outcome. A case-control study 190
The Italian neuromuscular registry: A coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage 190
Early predictors of oxaliplatin-induced cumulative neuropathy in colorectal cancer patients 189
Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools 189
Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review 188
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 188
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNoms study 188
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 188
Atypical CIDP: Diagnostic criteria, progression and treatment response. Data from the Italian CIDP Database 187
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice 187
A clinico-pathological and follow up study of 10 cases of essential type II cryoglobulinaemic neuropathy 186
Validation of the Italian version of the Neuropathic Pain Symptom Inventory in peripheral nervous system diseases 186
Totale 24.306
Salva come PNG Salva come JPEG
Categoria #
all - tutte 346.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 346.233
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.079 0 0 0 0 0 0 0 0 0 900 898 281
2020/202111.730 705 487 1.422 1.222 840 908 1.351 1.075 1.006 1.072 606 1.036
2021/20227.268 464 759 732 672 492 676 355 400 350 499 561 1.308
2022/202312.644 1.552 3.530 1.184 1.077 893 1.970 170 657 896 141 314 260
2023/202410.575 335 389 450 424 1.434 2.369 1.959 439 786 247 246 1.497
2024/202517.501 1.585 2.872 1.748 1.200 2.163 931 1.391 976 2.945 1.690 0 0
Totale 94.008